EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Kraig Biocraft Laboratories's enterprise value is $105.76 Mil.
Kraig Biocraft Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.52 Mil. Therefore, Kraig Biocraft Laboratories's EV-to-EBITDA for today is -42.02.
The historical rank and industry rank for Kraig Biocraft Laboratories's EV-to-EBITDA or its related term are showing as below:
KBLB'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -448.17 Med: 0 Max: 0
Current: -42.02
KBLB's EV-to-EBITDA is ranked worse than 100% of 1298
companies
in the Chemicals industry
Industry Median: 13.37
vs KBLB: -42.02
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-23), Kraig Biocraft Laboratories's stock price is $0.09617.
Kraig Biocraft Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.004. Therefore, Kraig Biocraft Laboratories's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Kraig Biocraft Laboratories EV-to-EBITDA Historical Data
The historical data trend for Kraig Biocraft Laboratories's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kraig Biocraft Laboratories EV-to-EBITDA Distribution
For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Kraig Biocraft Laboratories's EV-to-EBITDA falls into.
Kraig Biocraft Laboratories's current Enterprise Value is $105.76 Mil.
Kraig Biocraft Laboratories's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Kraig Biocraft Laboratories's PE Ratio for today is calculated as:
Kraig Biocraft Laboratories's share price for today is $0.09617.
Kraig Biocraft Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.004.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Kraig Biocraft Laboratories EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Business Description
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra. It generates the majority of its revenues from its business across the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KBLB has been successfully added to your 